JP2022505707A5 - - Google Patents

Info

Publication number
JP2022505707A5
JP2022505707A5 JP2021522353A JP2021522353A JP2022505707A5 JP 2022505707 A5 JP2022505707 A5 JP 2022505707A5 JP 2021522353 A JP2021522353 A JP 2021522353A JP 2021522353 A JP2021522353 A JP 2021522353A JP 2022505707 A5 JP2022505707 A5 JP 2022505707A5
Authority
JP
Japan
Prior art keywords
methyl
triazolo
pyridine
indazole
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021522353A
Other languages
English (en)
Japanese (ja)
Other versions
JP7597709B2 (ja
JP2022505707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057311 external-priority patent/WO2020086503A1/en
Publication of JP2022505707A publication Critical patent/JP2022505707A/ja
Publication of JP2022505707A5 publication Critical patent/JP2022505707A5/ja
Application granted granted Critical
Publication of JP7597709B2 publication Critical patent/JP7597709B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021522353A 2018-10-24 2019-10-22 置換インドールおよびインダゾール化合物 Active JP7597709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862749828P 2018-10-24 2018-10-24
US62/749,828 2018-10-24
PCT/US2019/057311 WO2020086503A1 (en) 2018-10-24 2019-10-22 Substituted indole and indazole compounds

Publications (3)

Publication Number Publication Date
JP2022505707A JP2022505707A (ja) 2022-01-14
JP2022505707A5 true JP2022505707A5 (cg-RX-API-DMAC7.html) 2022-10-26
JP7597709B2 JP7597709B2 (ja) 2024-12-10

Family

ID=68542773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522353A Active JP7597709B2 (ja) 2018-10-24 2019-10-22 置換インドールおよびインダゾール化合物

Country Status (7)

Country Link
US (1) US12172995B2 (cg-RX-API-DMAC7.html)
EP (1) EP3870583B1 (cg-RX-API-DMAC7.html)
JP (1) JP7597709B2 (cg-RX-API-DMAC7.html)
KR (1) KR102839382B1 (cg-RX-API-DMAC7.html)
CN (1) CN112955450A (cg-RX-API-DMAC7.html)
ES (1) ES3070130T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020086503A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
KR102513463B1 (ko) 2020-11-26 2023-03-29 주식회사 에스앤케이테라퓨틱스 엔도솜 톨-유사 수용체를 제어하는 신규 소분자 화합물 및 이를 이용한 자가면역질환 치료제
US11661431B2 (en) 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds
KR102678127B1 (ko) 2021-07-22 2024-06-25 경희대학교 산학협력단 신규한 퀴논 유도체
TW202440078A (zh) 2021-09-10 2024-10-16 美商基利科學股份有限公司 噻吩并吡咯化合物
CN114591339B (zh) * 2022-05-10 2022-08-02 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用
WO2026002036A1 (zh) * 2024-06-26 2026-01-02 北京双鹤润创科技有限公司 一种化合物及其用途

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
HUP0104987A3 (en) 1998-12-18 2002-09-30 Axys Pharmaceuticals Inc South Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
WO2001029025A2 (en) 1999-10-19 2001-04-26 Merck & Co., Inc. Tyrosine kinase inhibitors
AU2002353186A1 (en) 2001-12-19 2003-06-30 Smithkline Beecham P.L.C. (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
DE60305446T4 (de) 2002-01-07 2009-07-09 Eisai R&D Management Co., Ltd. Desazapurine und deren verwendung
DE10209520A1 (de) 2002-03-04 2003-09-25 4Sc Ag Neue Modulatoren von Kaliumkanälen
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US7410975B2 (en) 2003-06-20 2008-08-12 Coley Pharmaceutical Group, Inc. Small molecule toll-like receptor (TLR) antagonists
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
PT1899333E (pt) 2005-06-27 2009-04-23 Sanofi Aventis Derivados pirazolopiridina como inibidores da cinase do receptor beta-adrenérgico 1
JP2009532501A (ja) 2006-04-04 2009-09-10 ミリアド ジェネティクス, インコーポレイテッド 疾患および障害のための化合物
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
ATE495743T1 (de) 2006-12-01 2011-02-15 Galapagos Nv Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
CA2728559A1 (en) 2008-07-03 2010-01-07 Exelixis Inc. Cdk modulators
US8354400B2 (en) 2008-09-26 2013-01-15 Eisai R&D Co., Ltd. Benzoxazole compounds and methods of use
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
PL2453895T3 (pl) 2009-07-16 2018-10-31 Mallinckrodt Llc (+)-morfinany jako antagonisty receptora toll-like 9 i ich zastosowania terapeutyczne
BR112012006630A2 (pt) 2009-09-24 2016-05-03 Hoffmann La Roche derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
AU2010310449A1 (en) 2009-10-22 2012-05-03 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
MX346387B (es) 2011-01-12 2017-03-02 Ventirx Pharmaceuticals Inc Benzoazepinas sustituidas como moduladores de receptores tipo toll.
DK2663555T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
BR112013030894A2 (pt) 2011-06-01 2016-08-16 Janus Biotherapeutics Inc moduladores do sistema imune
AU2012262021B2 (en) 2011-06-01 2016-07-28 Janus Biotherapeutics, Inc. Novel immune system modulators
KR101913619B1 (ko) 2011-06-09 2018-12-28 리젠 파마슈티컬스 소시에떼 아노님 Gpr-119의 조절제로서의 신규한 화합물
CN103874702B (zh) 2011-07-15 2015-12-09 杨森制药公司 作为γ分泌酶调节剂的经取代的吲哚衍生物
CA2850932A1 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
CA2871589C (en) 2012-05-18 2020-12-22 Seiji Hori Pyrimidine carboxylic acid derivatives and their use as tlr7 agonists
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9761813B2 (en) 2012-08-10 2017-09-12 Doosan Corporation Organic light-emitting compound and organic electroluminescent device using same
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
KR101823488B1 (ko) 2013-10-14 2018-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 선택적으로 치환된 퀴놀린 화합물
US9643967B2 (en) 2013-12-13 2017-05-09 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
US20170275287A1 (en) 2014-08-22 2017-09-28 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
EP3218378B1 (en) 2014-11-14 2020-01-08 Nerviano Medical Sciences S.r.l. 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CN109715617B (zh) 2016-07-30 2022-04-19 百时美施贵宝公司 作为tlr7、tlr8或tlr9抑制剂的二甲氧基苯基取代的吲哚化合物
ES2902504T3 (es) 2016-09-09 2022-03-28 Bristol Myers Squibb Co Compuestos de indol sustituidos con piridilo
EA202091474A1 (ru) 2017-12-19 2020-11-18 Бристол-Маерс Сквибб Компани Замещенные индольные соединения, применимые в качестве ингибиторов tlr

Similar Documents

Publication Publication Date Title
JP4310109B2 (ja) ピラゾリル基を置換基として有する含窒素縮合環化合物およびその医薬組成物
ES2642586T3 (es) Compuestos heterocíclicos condensados como moduladores de canales iónicos
JP4638355B2 (ja) チアゾール誘導体
RU2017105296A (ru) Новые соединения
JP2012532931A5 (cg-RX-API-DMAC7.html)
JP2016523911A5 (cg-RX-API-DMAC7.html)
JP2020514267A5 (cg-RX-API-DMAC7.html)
JP2016500073A5 (cg-RX-API-DMAC7.html)
JP2017530960A5 (cg-RX-API-DMAC7.html)
JP2019519484A5 (cg-RX-API-DMAC7.html)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
JP2019528247A5 (cg-RX-API-DMAC7.html)
EA018721B1 (ru) Модуляторы сигнального пути hedgehog
EP2920177A1 (en) Compounds and compositions for the treatment of parasitic diseases
JP2017515836A5 (cg-RX-API-DMAC7.html)
JP2018524367A5 (cg-RX-API-DMAC7.html)
JP2016518344A5 (cg-RX-API-DMAC7.html)
HRP20150185T1 (hr) Inhibitori kinaza koji reguliraju signalne puteve u apoptozi
KR20030030030A (ko) IKB-키나제 (IKK-β) 억제 활성을 갖는 피리딘 유도체
RU2015144386A (ru) Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы
JP2006519205A (ja) ピラゾロピリジン誘導体
JP2016519096A5 (cg-RX-API-DMAC7.html)
JP2017508766A5 (cg-RX-API-DMAC7.html)
JP2023525762A5 (cg-RX-API-DMAC7.html)